TCL Archive Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival October 25, 2013
TCL Archive Senate Committee Approves Additional $400 Million For NCI, $275 Million For FDA. May 16, 2008
TCL Archive Patients Sue Milken, Cancer Centers, Over Prostate Cancer Remedy PC-Spes February 20, 2004